Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
5.26
+0.46 (9.58%)
At close: Mar 9, 2026, 4:00 PM EDT
5.32
+0.06 (1.14%)
After-hours: Mar 9, 2026, 6:56 PM EDT
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $316.56 million as of March 9, 2026. Its market cap has decreased by -20.90% in one year.
Market Cap
316.56M
Enterprise Value
256.03M
1-Year Change
-20.90%
Ranking
Category
Stock Price
$5.26
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $316.56M, an increase of 750.97%. That is a compound annual growth rate of 19.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 288.90M | -7.28% |
| Dec 31, 2025 | 311.60M | 4.85% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 308.86M |
| Puma Biotechnology | 307.80M |
| Cabaletta Bio | 305.16M |
| C4 Therapeutics | 296.64M |
| Silence Therapeutics | 294.27M |
| ALX Oncology Holdings | 289.95M |
| Context Therapeutics | 286.66M |
| AC Immune | 276.05M |